ApoE knockout rabbits: A novel model for the study of human hyperlipidemia

Atherosclerosis

Volumn 245, Issue , 2016, Pages 187-193

  Niimi, Manabu ^a   Yang, Dongshan ^b   Kitajima, Shuji ^c   Ning, Bo ^a   Wang, Chuan ^a   Li, Shen ^a   Liu, Enqi ^d   Zhang, Jifeng ^b   Eugene Chen, Y ^b   Fan, Jianglin ^a,e  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c SAGA UNIVERSITY   (Japan)

^d MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^e XI'AN MEDICAL UNIVERSITY   (China)

Author keywords

Apolipoprotein E; Genome editing; Hyperlipidemia; Knockout; Lipoprotein metabolism; Rabbit

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN B48; APOLIPOPROTEIN E; INTERMEDIATE DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; APOE KNOCKOUT RABBIT; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CONTROLLED STUDY; DISEASE PREDISPOSITION; HOMOZYGOTE; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; NONHUMAN; PRIORITY JOURNAL; RABBIT MODEL; WILD TYPE RABBIT; AGAR GEL ELECTROPHORESIS; ANIMAL; BLOOD; DISEASE MODEL; GENETIC PREDISPOSITION; GENETICS; HUMAN; IMMUNOBLOTTING; MALE; RABBITS AND HARES;

ANIMALS; APOLIPOPROTEINS E; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, AGAR GEL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERLIPIDEMIAS; IMMUNOBLOTTING; MALE; RABBITS;

EID: 84951742889     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.12.002     Document Type: Article

References (25)

1. Fan J., Kitajima S., Watanabe T., Xu J., Zhang J., Liu E., Chen Y.E. Rabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicine. Pharmacol. Ther. 2015, 146:104-119.
2. Tall A.R. Plasma cholesteryl ester transfer protein. J. Lipid Res. 1986, 27:361-367.
3. Fan J., Watanabe T. Transgenic rabbits as therapeutic protein bioreactors and human disease models. Pharmacol. Ther. 2003, 99:261-282.
4. Shiomi M., Ito T. The watanabe heritable hyperlipidemic (WHHL) rabbit, its characteristics and history of development: a tribute to the late Dr. Yoshio Watanabe. Atherosclerosis 2009, 207:1-7.
5. Gaj T., Gersbach C.A., Barbas C.F. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol. 2013, 31:397-405.
6. Yang D., Zhang J., Xu J., Zhu T., Fan Y., Fan J., Chen Y.E. Production of apolipoprotein C-III knockout rabbits using zinc finger nucleases. J. Vis. Exp. 2013, 81:e50957.
7. Yang D., Xu J., Zhu T., Fan J., Lai L., Zhang J., Chen Y. Effective gene targeting in rabbits using RNA-guided Cas9 nucleases. J. Mol. Cell Biol. 2014, 6:97-99.
8. Ji D., Zhao G., Songstad A., Cui X., Weinstein E.J. Efficient creation of an APOE knockout rabbit. Transgenic Res. 2015, 24:227-235.
9. Wang Y., Niimi M., Nishijima K., Yu Y., Koike T., Kitajima K., Inoue T., Waqar A.B., Liu E., Kohashi M., Ketamura Y., Yoshikawa T., Zhang J., Ma L., Zha X., Watanabe T., Asada Y., Chen E.Y., Fan J. Human apolipoprotein A-II protects against diet-induced atherosclerosis in transgenic rabbits. Arterioscler. Thromb. Vas. Biol. 2013, 33:224-231.
10. Fan J., Unoki H., Kojima N., Sun H., Shimoyamada H., Deng H., Okazaki M., Shikama H., Yamada N., Watanabe T. Overexpression of lipoprotein lipase in transgenic rabbits inhibits diet-induced hypercholesterolemia and atherosclerosis. J. Biol. Chem. 2001, 276:40071-40079.
11. Fan J., Ji Z.S., Huang Y., de Silva H., Sanan D., Mahley R.W., Innerarity T.L., Taylor J.M. Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma. J. Clin. Invest. 1998, 101:2151-2164.
12. Koike T., Liang J., Wang X., Ichikawa T., Shiomi M., Sun H., Watanabe T., Liu G., Fan J. Enhanced aortic atherosclerosis in transgenic Watanabe heritable hyperlipidemic rabbits expressing lipoprotein lipase. Cardiovasc. Res. 2005, 65:524-534.
13. Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988, 240:622-630.
14. Mahley R.W., Huang Y., Rall S.C. Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia): questions, quandaries, and paradoxes. J. Lipid Res. 1999, 40:1933-1949.
15. Zhang S.H., Reddick R.L., Piedrahita J.A., Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992, 258:468-471.
16. Plump A.S., Smith J.D., Hayek T., Aalto-Setala K., Walsh A., Verstuyft J.G., Rubin E.M., Breslow J.L. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992, 71:343-353.
17. Mabuchi H., Itoh H., Takeda M., Kajinami K., Wakasugi T., Koizumi J., Takeda R., Asagami C. A young type III hyperlipoproteinemic patient associated with apolipoprotein E deficiency. Metabolism 1989, 38:115-119.
18. Ghiselli G., Schaefer E.J., Gascon P., Breser H.B. Type III hyperlipoproteinemia associated with apolipoprotein E deficiency. Science 1981, 214:1239-1241.
19. Bellosta S., Mahley R.W., Sanan D.A., Murata J., Newland D.L., Taylor J.M., Pitas R.E. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice. J. Clin. Invest. 1995, 96:2170-2179.
20. Linton M.F., Atkinson J.B., Fazio S. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science 1995, 267:1034-1037.
21. Ishibashi S., Goldstein J.L., Brown M.S., Herz J., Burns D.K. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J. Clin. Invest. 1994, 93:1885-1893.
22. Maeda N. Development of apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2011, 31:1957-1962.
23. Goldberg A.C., Hopkins P.N., Toth P.P., Ballantyne C.M., Rader D.J., Robinson J.G., Daniels S.R., Gidding S.S., de Ferranti S.D., Ito M.K., McGowan M.P., Moriarty P.M., Cromwell W.C., Ross J.L., Ziajka P.E. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients clinical guidance from the national lipid association expert panel on familial hypercholesterolemia. J. Clin. Lipidol. 2011, 5:133-140.
24. Ishibashi S., Brown M.S., Goldstein J.L., Gerard R.D., Hammer R.E., Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 1993, 92:883-893.
25. Fan J., Wang J., Bensadoun A., Lauer S.J., Dang Q., Mahley R.W., Taylor J.M. Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:8724-8728.